Refine
Year of publication
Document Type
- Article (297)
- Preprint (181)
- Conference Proceeding (4)
- Book (2)
- Review (2)
Language
- English (471)
- German (14)
- Multiple languages (1)
Has Fulltext
- yes (486)
Is part of the Bibliography
- no (486)
Keywords
- e +-e − Experiments (15)
- BESIII (12)
- Branching fraction (10)
- Particle and Resonance Production (8)
- Charm Physics (6)
- Spectroscopy (6)
- Quarkonium (5)
- Exotics (4)
- Lepton colliders (4)
- Charmed mesons (3)
- Electroweak interaction (3)
- Hadronic decays (3)
- e+-e− Experiments (3)
- Biomarkers (2)
- Branching fractions (2)
- CV9202 (2)
- Charm physics (2)
- Charmonium (2)
- Consensus (2)
- Diagnostik (2)
- Electroweak Interaction (2)
- Flavour Physics (2)
- Früherkennung (2)
- Leptonic, semileptonic & radiative decays (2)
- MRI (2)
- Mammakarzinom (2)
- Nachsorge (2)
- Non-small cell lung cancer (2)
- Oncology (2)
- Particle decays (2)
- Polarization (2)
- QCD (2)
- Radiative decay (2)
- Rehabilitation (2)
- Richtlinie (2)
- SARS-CoV-2 (2)
- breast cancer (2)
- diagnosis (2)
- follow‑up (2)
- guideline (2)
- screening (2)
- ACL (1)
- ATM (1)
- Absolute branching fraction (1)
- Actin (1)
- Active middle ear implants (1)
- Activities of daily living (1)
- Acute inflammation (1)
- Acute myeloid leukemia (1)
- Alzheimer's disease (1)
- Animal models (1)
- Aniridia (1)
- Antiretroviral therapy (1)
- Antiretrovirals (1)
- Antirheumatic agents (1)
- Aphakia (1)
- Archaeogeophysics (1)
- Artificial iris (1)
- Ascites (1)
- Auditory system (1)
- Austria (1)
- Automata theory (1)
- B cell receptor (1)
- BESIII detector (1)
- BI1361849 (1)
- BPDCN (1)
- Berci needle (1)
- Bevacizumab (1)
- Bhabha (1)
- Bone conduction devices (1)
- Born cross section (1)
- Born cross section measurement (1)
- BrainNet Europe consortium (1)
- Branching fraction measurement (1)
- Business strategy in drug development (1)
- Bypass liner (1)
- C1-INH (C1 inhibitor, C1-esterase inhibitor) (1)
- CAKUT (1)
- CDKN2A (1)
- COVID-19 (1)
- CP violation (1)
- CRISPR/Cas (1)
- Cancer (1)
- Capecitabine (1)
- Cardiomyopathy (1)
- Carex firma community (1)
- Carex sempervirens community (1)
- Caricion davallianae (1)
- Charm vector (1)
- Charmed baryon (1)
- Charmonia (1)
- Charmonium (-like) (1)
- Cherenkov counter: lead-glass (1)
- Child (1)
- Chondral Lesion (1)
- Cirrhosis (1)
- Claudin 5 (1)
- Clinical trial (1)
- Cognitive impairment (1)
- Cohort studies (1)
- Comparative effectiveness research (1)
- Complex I (1)
- Consensus statement (1)
- Covid-19 (1)
- Cross section (1)
- D meson (1)
- Dark photon (1)
- Dark sector (1)
- Dermatomyositis (1)
- Diabetes (1)
- Diagnosis (1)
- Diagnostic differentiation (1)
- Diagnostic markers (1)
- Dilated cardiomyopathy (1)
- Direct oral anticoagulation (1)
- Drug screens (1)
- Drug therapy (1)
- Dumon stents (1)
- Effective form factor (1)
- Electromagnetic form factor (1)
- Electromagnetic form factors (1)
- Electron-pion identification (1)
- Endoscopy (1)
- Esophageal adenocarcinoma (1)
- Exercise (1)
- Experimental nuclear physics (1)
- Experimental particle physics (1)
- FAPI PET (1)
- FOS: Physical sciences (1)
- Fagus sylvatica (1)
- Festuco-Brometea (1)
- Fibre/foam sandwich radiator (1)
- Flavor changing neutral currents (1)
- Flavor symmetries (1)
- Form factors (1)
- Full waveform (1)
- Function (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Genome editing (1)
- Glioblastoma survival (1)
- HADES (1)
- HIV (1)
- HIV-1 (1)
- Haploidentical stem cell transplantation (1)
- Harz Mountains foothills (1)
- Health policy (1)
- Heart (1)
- Heart transplantation (1)
- Heavy ion storage ring (1)
- Helicity amplitude analysis (1)
- Hematology (1)
- Hepatitis C virus (1)
- Hereditary angioedema (1)
- High Energy Physics - Experiment (hep-ex) (1)
- Hsp70 (1)
- Hyperons (1)
- Hypofractionated radiotherapy (1)
- IHC (1)
- IOL scleral Fixation (1)
- Immunomonitoring (1)
- Inclusive branching fraction (1)
- Infinite games with perfect information (1)
- Initial state radiation (1)
- Interpretation (1)
- Intragastric balloon (1)
- Inversion (1)
- Invisible decays (1)
- Ionisation energy loss (1)
- K0S (1)
- KIR (1)
- KRAS (1)
- Lactic acidosis (1)
- Leukemias (1)
- Liver diseases (1)
- Liver transplantation (1)
- Low-molecular-weight heparin (1)
- MEDIC (1)
- MLL (1)
- Mena/VASP (1)
- Minimal residual disease (1)
- Mitochondrial disorder (1)
- Mixed hearing loss (1)
- Molecular diagnostic testing (1)
- Molinio-Arrhenatheretea (1)
- Multi-stakeholder approach (1)
- Multi-wire proportional drift chamber (1)
- NK cells (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NRAS (1)
- Neonatal (1)
- Neural network (1)
- Neutrinos (1)
- Noninferiority (1)
- Obesity (1)
- Ocular trauma (1)
- Orbital electron capture (1)
- Ovarian cancer (1)
- Oxaliplatin (1)
- PDE‐5‐inhibitor (1)
- Parkinson disease (1)
- Particle and resonance production (1)
- Particle phenomena (1)
- Patellofemoral Joint (1)
- Pediatric (1)
- Physiotherapy (1)
- Preoperative radiochemotherapy (1)
- Prognosis (1)
- Proton (1)
- Pulmonary embolism (1)
- Quantum chromodynamics (1)
- RHIC (1)
- RNActive (1)
- Rare decays (1)
- Rectal cancer (1)
- Registries (1)
- Renal lesions (1)
- Renal replacement therapy (1)
- Respiration (1)
- SCCHN (1)
- SLC20A1 (1)
- STAR (1)
- STIR (1)
- Semi-leptonic decays (1)
- Single particle decay spectroscopy (1)
- Single-leg hop for distance (1)
- Spectrin (1)
- Spin alignment (1)
- Surgery (1)
- TILs (1)
- TLR2/6 (1)
- TR (1)
- Technical data (1)
- Techniques Electromagnetic calorimeters (1)
- Therapeutic anticoagulation (1)
- Threshold effect (1)
- Tomography (1)
- Tracking (1)
- Transition radiation detector (1)
- Treatment (1)
- Trigger (1)
- Two body weak decay (1)
- VE-cadherin (1)
- VEGF (1)
- VISTA (1)
- Validity (1)
- Vascular permeability (1)
- Violion caninae (1)
- Vitamin (1)
- Weight loss (1)
- Xenon-based gas mixture (1)
- Y states (1)
- Yamane (1)
- acute myeloid leukemia (1)
- adult and elderly patients (1)
- aegean (1)
- airway (1)
- algorithms (1)
- alpine vegetation (1)
- angiogenesis (1)
- annual bleeding rate (1)
- arteriogenesis (1)
- artifacts (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- auditory system (1)
- beech forests (1)
- bladder exstrophy-epispadias complex (1)
- blastic plasmacytoid dendritic cell neoplasm (1)
- blood flow recovery (1)
- bone-marrow (1)
- calorimeter: electromagnetic (1)
- center-of-mass energy (1)
- cerebral sinus and vein thrombosis (CVT) (1)
- charmonium-like states (1)
- cisplatin (1)
- cloacal malformation (1)
- coastal geomorphology (1)
- cohlear implant (1)
- collateral growth (1)
- combinatorics (1)
- comorbidity (1)
- component study (1)
- cone-beam computed tomography (CBCT) (1)
- cone-beam computer tomography (1)
- coronary artery disease (1)
- cytarabine dose (1)
- dE/dx (1)
- data quality (1)
- data structures (1)
- decays (1)
- decompressive craniectomy (1)
- denervation (1)
- dimuon (1)
- dynamic vegetation model (1)
- e+e − annihilation (1)
- e+e⁻ − Experiments (1)
- e+e− Experiments (1)
- early tumor stages (1)
- effectiveness (1)
- elderly (1)
- electric and acustic stymulation (1)
- electrical resistivity tomography (1)
- electroencephalography (EEG) (1)
- electromagnetic navigation bronchoscopy (EMN, ENB) (1)
- electron-positron collision (1)
- electronics: readout (1)
- endothelial function (1)
- erectile dysfunction (1)
- femoral artery ligation (1)
- fibre: optical (1)
- fibrosis imaging (1)
- fluid shear stress (1)
- foraminifera (1)
- functional genetics (1)
- geophysical prospections (1)
- global warming (1)
- hadron spectroscopy (1)
- hadronic events (1)
- haemophilia A (1)
- hearing loss (1)
- helicity amplitude analysis (1)
- hierarchies and reducibilities (1)
- immunohistochemistry (1)
- inclusive J/ψ decays (1)
- inner ear (1)
- intracerebral hemorrhage (ICH) (1)
- intratumoral (1)
- kidney formation (1)
- lipiodol (1)
- local radiotherapy (1)
- logic (1)
- lung cancer (1)
- mRNA active cancer immunotherapy (1)
- mRNA vaccine (1)
- magnetic gradiometry (1)
- micropalaeontology (1)
- microwave ablation (1)
- mindfulness (1)
- monocytes (1)
- multicenter study (1)
- mutually exclusive mutations (1)
- mycorrhiza (1)
- nanoparticle (1)
- natural reforestation (1)
- neurofibrillary pathology (1)
- neuropathological diagnosis (1)
- neutralizing antibodies (1)
- next generation sequencing (1)
- nitrogen deposition (1)
- non-small cell lung cancer (1)
- non‐selective beta‐blocker (1)
- nuclear cardiology (1)
- number of J/ψ events (1)
- nutrient cycling (1)
- permanent plots (1)
- plant community assembly (1)
- plant functional traits (1)
- plant succession (1)
- plasma-derived factor VIII concentrate, prophylaxis (1)
- portal hypertension (1)
- prognosis (1)
- prognostic biomarker (1)
- psychotherapy process (1)
- pulmonary hypertension (1)
- radiation (1)
- randomized controlled trial (RCT) (1)
- reactive systems (1)
- recurrent mutations (1)
- retrospective trial (1)
- rolipram (1)
- solitary pulmonary nodule (1)
- species composition (1)
- species richness (1)
- specification and verification (1)
- spike protein (1)
- spiral ganglion cell (1)
- stability (1)
- stent (1)
- succession (1)
- tetraquark (1)
- therapeutic alliance (1)
- tracheobronchomalacia (1)
- transbronchial biopsy (TBB) (1)
- trigger efficiency (1)
- tropical montane forests (TMF) (1)
- urinary tract development (1)
- vaccination (1)
- vaccine-induced immune thrombotic thrombocytopenia (VITT) (1)
- variants of concern (1)
- vegetation classification (1)
- verification (1)
- von Willebrand disease (1)
- windthrow (1)
- zebrafish development (1)
- Λ+c baryon (1)
- Σ hyperon (1)
- ψ(3686) (1)
Institute
We measure the Born cross sections of the process 𝑒+𝑒−→𝐾+𝐾−𝐾+𝐾− at center-of-mass (c.m.) energies, √𝑠, between 2.100 and 3.080 GeV. The data were collected using the BESIII detector at the BEPCII collider. An enhancement at √𝑠=2.232 GeV is observed, very close to the 𝑒+𝑒−→Λ¯Λ production threshold. A similar enhancement at the same c.m. energy is observed in the 𝑒+𝑒−→𝜙𝐾+𝐾− cross section. The energy dependence of the 𝐾+𝐾−𝐾+𝐾− and 𝜙𝐾+𝐾− cross sections differs significantly from that of 𝑒+𝑒−→𝜙𝜋+𝜋−.
Using 𝑒+𝑒−→Λ+𝑐¯Λ−𝑐 production from a 567 pb−1 data sample collected by BESIII at 4.6 GeV, a full angular analysis is carried out simultaneously on the four decay modes of Λ+𝑐→𝑝𝐾0𝑆, Λ𝜋+, Σ+𝜋0, and Σ0𝜋+. For the first time, the Λ+𝑐 transverse polarization is studied in unpolarized 𝑒+𝑒− collisions, where a nonzero effect is observed with a statistical significance of 2.1𝜎. The decay asymmetry parameters of the Λ+𝑐 weak hadronic decays into 𝑝𝐾0𝑆, Λ𝜋+, Σ+𝜋0 and Σ0𝜋+ are measured to be 0.18±0.43(stat)±0.14(syst), −0.80±0.11(stat)±0.02(syst), −0.57±0.10(stat)±0.07(syst), and −0.73±0.17(stat)±0.07(syst), respectively. In comparison with previous results, the measurements for the Λ𝜋+ and Σ+𝜋0 modes are consistent but with improved precision, while the parameters for the 𝑝𝐾0𝑆 and Σ0𝜋+ modes are measured for the first time.
A partial-wave analysis of the decay 𝐽/𝜓→𝐾+𝐾−𝜋0 has been made using (223.7±1.4)×106 𝐽/𝜓 events collected with the BESIII detector in 2009. The analysis, which is performed within the isobar-model approach, reveals contributions from 𝐾*2(1430)±, 𝐾*2(1980)± and 𝐾*4(2045)± decaying to 𝐾±𝜋0. The two latter states are observed in 𝐽/𝜓 decays for the first time. Two resonance signals decaying to 𝐾+𝐾− are also observed. These contributions cannot be reliably identified and their possible interpretations are discussed. The measured branching fraction 𝐵(𝐽/𝜓→𝐾+𝐾−𝜋0) of (2.88±0.01±0.12)×10−3 is more precise than previous results. Branching fractions for the reported contributions are presented as well. The results of the partial-wave analysis differ significantly from those previously obtained by BESII and BABAR.
The singly Cabibbo-suppressed decay D+s → K+π+π−π0 is observed by using a data set corresponding to an integrated luminosity of 6.32 fb−1 recorded by the BESIII detector at the centre-of-mass energies between 4.178 and 4.226 GeV. The first amplitude analysis of D+s → K+π+π−π0 reveals the sub-structures in this decay and determines the fractions and relative phases of different intermediate processes. The dominant intermediate process is D+s → K∗0ρ+, with a fit fraction of (40.5 ± 2.8stat. ± 1.5syst.)%. With the detection efficiency based on our amplitude analysis, the absolute branching fraction forD+s → K+π+π−π0 is measured to be (9.75 ± 0.54stat. ± 0.17syst.) × 10−3.
Using 2.93 fb−1 of e+e− collision data collected with the BESIII detector at the center-of-mass energy 3.773 GeV, we perform the first amplitude analysis of the decay D+ → π+π0π0 and determine the relative magnitudes and phases of different intermediate processes. The absolute branching fraction of D+ → π+π0π0 is measured to be (2.888 ± 0.058stat. ± 0.069syst.)%. The dominant intermediate processes are D+ → a1(1260)+(→ ρ+π0) and D+ → *0ρ+, with branching fractions of (8.66 ± 1.04stat. ± 1.39syst.) × 10−3 and (9.70 ± 0.81stat. ± 0.53syst.) × 10−3, respectively.
Using (27.12±0.14)×108 ψ(3686) events collected with the BESIII detector at BEPCII, the decay of ψ(3686)→Ω−K+Ξ¯0+c.c. is observed for the first time. The branching fraction of this decay is measured to be Bψ(3686)→Ω−K+Ξ¯0+c.c.=(2.78±0.40±0.18)×10−6, where the first uncertainty is statistical and the second is systematic. Possible baryon excited states are searched for in this decay, but no evident intermediate state is observed with the current sample size.
Using an 𝑒+𝑒− collision data sample with a total integrated luminosity of 3.19 fb−1 collected with the BESIII detector at a center-of-mass energy of 4.178 GeV, the branching fraction of the inclusive decay of the 𝐷+𝑠 meson to final states including at least three charged pions is measured for the first time to be ℬ(𝐷+𝑠→𝜋+𝜋+𝜋−𝑋)=(32.81±0.35stat±0.63syst)%. In this measurement the charged pions from 𝐾0𝑆 meson decays are excluded. The partial branching fractions of 𝐷+𝑠→𝜋+𝜋+𝜋−𝑋 are also measured as a function of the 𝜋+𝜋+𝜋− invariant mass.
Using 15.6 fb−1 of e+e− collision data collected at twenty-four center-of-mass energies from 4.0 to 4.6 GeV with the BESIII detector, the helicity amplitudes of the process e+e− → π+π−ω are analyzed for the first time. Born cross section measurements of two-body intermediate resonance states with statistical significance greater than 5σ are presented, such as f0(500), f0(980), f2(1270), f0(1370), b1(1235)±, and ρ(1450)±. In addition, evidence of a resonance state in e+e− → π+π−ω production is found. The mass of this state obtained by line shape fitting is about 4.2 GeV/c2, which is consistent with the production of ψ(4160) or Y(4220).
Using 15.6 fb−1 of e+e− collision data collected at twenty-four center-of-mass energies from 4.0 to 4.6 GeV with the BESIII detector, the helicity amplitudes of the process e+e−→π+π−ω are analyzed for the first time. Born cross section measurements of two-body intermediate resonance states with statistical significance greater than 5σ are presented, such as f0(500), f0(980), f2(1270), f0(1370), b1(1235)±, and ρ(1450)±. In addition, evidence of a resonance state in e+e−→π+π−ω production is found. The mass of this state obtained by line shape fitting is about 4.2 GeV/c2, which is consistent with the production of ψ(4160) or Y(4220).
We report a search for a dark photon using 14.9~fb−1 of e+e− annihilation data taken at center-of-mass energies from 4.13 to 4.60~GeV with the BESIII detector operated at the BEPCII storage ring. The dark photon is assumed to be produced in the radiative annihilation process of e+e− and to predominantly decay into light dark matter particles, which escape from the detector undetected. The mass range from 1.5 to 2.9~GeV is scanned for the dark photon candidate, and no significant signal is observed. The mass dependent upper limits at the 90% confidence level on the coupling strength parameter ϵ for a dark photon coupling with an ordinary photon vary between 1.6×10−3 and 5.7×10−3.